EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL F. Morschhauser, N. Ghosh, I. Lossos,M.L. Palomba,A. Mehta,O. Casasnovas,D. Stevens,S. Chitra, A. Knapp,T. Nielsen,M. Oestergaard,M. Wenger,G. SallesHematological Oncology（2019）引用 8|浏览55暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
